Biodexa provides update on PFS, OS in Phase 1 study of MTX110 in rGBM
PremiumThe FlyBiodexa provides update on PFS, OS in Phase 1 study of MTX110 in rGBM
14d ago
Biodexa Pharmaceuticals PLC-ADR trading halted, news pending
Premium
The Fly
Biodexa Pharmaceuticals PLC-ADR trading halted, news pending
14d ago
Biodexa’s MTX110 Shows Promise in Brain Cancer Study
Premium
Company Announcements
Biodexa’s MTX110 Shows Promise in Brain Cancer Study
15d ago
Biodexa anounces ratio change on its ADR, effective date October24
PremiumThe FlyBiodexa anounces ratio change on its ADR, effective date October24
30d ago
Biodexa Pharmaceuticals Advances FAP Treatment
Premium
Company Announcements
Biodexa Pharmaceuticals Advances FAP Treatment
1M ago
Biodexa Pharmaceuticals announces final match payment with respect to $17M grant
Premium
The Fly
Biodexa Pharmaceuticals announces final match payment with respect to $17M grant
1M ago
Biodexa Pharmaceuticals prices $5M registered direct offering at 94c per share
PremiumThe FlyBiodexa Pharmaceuticals prices $5M registered direct offering at 94c per share
3M ago
Biodexa’s Diabetes Drug Enters Phase 2a Studies
Premium
Company Announcements
Biodexa’s Diabetes Drug Enters Phase 2a Studies
3M ago
Biodexa Pharmaceuticals announces Phase 2a study of tolimidone in T1D
Premium
The Fly
Biodexa Pharmaceuticals announces Phase 2a study of tolimidone in T1D
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100